Sabatini Brent bought VIR
February 22, 2026 · Form 4 insider transaction
Sabatini Brent bought 25,000 shares of Vir Biotechnology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$0.00
Total value
N/A
InsiderSabatini Brent
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 22, 2026
Filing dateFebruary 24, 2026
Shares owned after72,872
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.